Group One Trading
KRTX

Group One Trading’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Group One Trading’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,000
Closed -$3.8M – 8208
2023
Q4 		$3.8M Buy
12,000
+7,100
+145% +$1.38M 0.01% 1342
2023
Q3 		$829K Sell
4,900
-1,300
-21% -$244K ﹤0.01% 2451
2023
Q2 		$1.34M Sell
6,200
-18,700
-75% -$4.01M ﹤0.01% 2075
2023
Q1 		$4.52M Sell
24,900
-1,400
-5% -$268K 0.02% 900
2022
Q4 		$5.17M Buy
26,300
+7,500
+40% +$1.61M 0.01% 1120
2022
Q3 		$4.23M Buy
18,800
+600
+3% +$121K 0.01% 1289
2022
Q2 		$2.3M Buy
+18,200
New +$2.09M ﹤0.01% 1923
2022
Q1 		– Sell
-200
Closed -$26K – 8939
2021
Q4 		$26K Sell
200
-2,200
-92% -$284K ﹤0.01% 6817
2021
Q3 		$294K Buy
2,400
+2,300
+2,300% +$266K ﹤0.01% 4771
2021
Q2 		$11K Hold
100
– – ﹤0.01% 7490
2021
Q1 		$12K Sell
100
-400
-80% -$45.3K ﹤0.01% 6981
2020
Q4 		$51K Buy
500
+200
+67% +$18.5K ﹤0.01% 4997
2020
Q3 		$23K Sell
300
-600
-67% -$51.1K ﹤0.01% 5067
2020
Q2 		$100K Buy
+900
New +$78.3K ﹤0.01% 3912

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Group One Trading's KRTX Position: Q1 2024 in Review

Group One Trading sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,644 shares — an estimated $837K sold.

Group One Trading first reported a position in KRTX in Q1 2020 and held it in 14 quarters. The position peaked at $1.6M in Q2 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Group One Trading reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 2,644 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $837K.
  • Group One Trading first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
  • Group One Trading's Karuna Therapeutics, Inc. Common Stock position peaked at $1.6M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.